Bipartisan legislation filed by House and Senate lawmakers this year could help to promote the production of generic drugs, impose regulations on high rebate pricing and allow officials to declare
Lawmakers are considering a bill to address what President Trump called a top priority in his State of the Union speech: lowering prescription drug prices. Critics say some drug companies
A record number of generic drugs were approved by the Food and Drug Administration last year. If President Trump has his way, that trend will continue or even accelerate
You’ve no doubt seen them in the grocery store typically drab-looking packages on the bottom shelf containing lower-priced generic versions of popular brand-name products. Some shoppers look at them
Amazon is talking with generic drug makers about possibly entering the health care market, reports CNBC. Anonymous sources say the company has had high-level talks with pharmaceutical company Mylan and
Donald Jones used to pay at least $500 a month for a brand-name drug, Gleevec, thats kept his leukemia at bay for five years. Lately, hes been paying almost as
One smart way to reduce the cost of health care, according to many experts, is to expand generic drugs. Scott Gottlieb, the new commissioner of the FDA, for example, wants
For a time, high drug prices made headlines, and it looked like the issue could be tackled by the Trump administration. But as we all know, efforts to repeal Obamacare
In September 2015, Satish Mehta, the billionaire chief executive of the Indian drug company Emcure Pharmaceuticals, wrote an effusive email congratulating Jeffrey Glazer, the CEO of his U.S. crown jewel,
Food and Drug Administration Commissioner Scott Gottlieb, MD, outlined his strategy to lower drug prices during a Monday interview with Bloomberg. Here are four ways Dr. Gottlieb seeks to address
